Feed Preview

Breast Cancer: Chemo-Resistance

Breast Cancer: Chemo-Resistance diagram by #N/A

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Top 20 most recent papers
Proceedings of the National Academy of Sciences of the United States of America

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

Proceedings of the National Academy of Sciences of the United States of AmericaDecember 11, 2019
Xiaoyong FuRachel Schiff
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

TBCRC 032 IB/II Multicenter Study: Molecular insights to AR antagonist and PI3K inhibitor efficacy in patients with AR+ metastatic triple-negative breast cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchDecember 10, 2019
Brian David LehmannJennifer A Pietenpol
Scientific Reports

miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB

Scientific ReportsDecember 11, 2019
Yu GaoGuanghua Li
Cancer Discovery

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer

Cancer DiscoveryDecember 5, 2019
Lillian M SmythDavid M. Hyman
Breast Cancer Research : BCR

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

Breast Cancer Research : BCRDecember 3, 2019
Samuel A JacobsKatherine L Pogue-Geile
Therapeutic Advances in Medical Oncology

The emerging role of CDK4/6i in HER2-positive breast cancer

Therapeutic Advances in Medical OncologyNovember 27, 2019
Ciara C O'SullivanMatthew P. Goetz
Breast Cancer Research : BCR

Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)

Breast Cancer Research : BCRNovember 28, 2019
Nur ZeinomarMary Beth Terry
EJNMMI Research

Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography

EJNMMI ResearchDecember 12, 2019
Beatrix WulkersdorferOliver Langer
Breast Cancer Research : BCR

Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy

Breast Cancer Research : BCRDecember 11, 2019
Bruno Valentin SinnSibylle Loibl
Cell Reports

CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies

Cell ReportsDecember 10, 2019
William W. FengManabu Kurokawa
Breast Cancer Research : BCR

The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis

Breast Cancer Research : BCRDecember 11, 2019
Bre-Anne FifieldLisa Ann Porter
Breast Cancer Research : BCR

Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer

Breast Cancer Research : BCRDecember 4, 2019
Sunil PancholiLesley-Ann Martin

Plant defensin PvD1 modulates the membrane composition of breast tumour-derived exosomes

NanoscaleDecember 3, 2019
Julia SkalskaDiana Gaspar
British Journal of Cancer

Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin

British Journal of CancerDecember 10, 2019
Simon R LordAdrian L. Harris
Pathology, Research and Practice

CMIP promotes Herceptin resistance of HER2 positive gastric cancer cells

Pathology, Research and PracticeDecember 2, 2019
Ru XiangZheng-Sheng Wu
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia

Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer

Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, CzechoslovakiaDecember 1, 2019
Iveta KolarovaMartin Dolezel
Biochemical and Biophysical Research Communications

Identification of FOXE3 transcription factor as a potent oncogenic factor in triple-negative breast cancer

Biochemical and Biophysical Research CommunicationsDecember 9, 2019
Hua WangXiao-Mian Sun
Breast Cancer Research : BCR

Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells

Breast Cancer Research : BCRDecember 5, 2019
Monica M MontanoMatthew C Lawes
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry

Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers

Molecules : a Journal of Synthetic Chemistry and Natural Product ChemistryNovember 30, 2019
Zintle MbeseBlessing Atim Aderibigbe
Breast Cancer Research and Treatment

TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties

Breast Cancer Research and TreatmentDecember 10, 2019
Kelly Kyker-SnowmanBen Ho Park

See more papers from this feed

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

© 2019 Meta ULC. All rights reserved